Rationale and protocol design for the TORG1835/NEXT-SHIP study: a phase II study of carboplatin, etoposide and nintedanib for unresectable limited/extensive disease small cell lung cancer with idiopathic pulmonary fibrosis

BACKGROUND: Interstitial pneumonia (IP) is one of the most common and poor prognostic comorbidities in patients with small cell lung cancer (SCLC). The pharmacotherapy for SCLC occasionally induces fatal acute exacerbation of comorbid IP, especially in patients with idiopathic pulmonary fibrosis (IP...

全面介紹

Na minha lista:
書目詳細資料
發表在:Ther Adv Med Oncol
Main Authors: Ikeda, Satoshi, Ogura, Takashi, Kato, Terufumi, Kenmotsu, Hirotsugu, Iwasawa, Tae, Misumi, Toshihiro, Yamanaka, Takeharu, Okamoto, Hiroaki
格式: Artigo
語言:Inglês
出版: SAGE Publications 2020
主題:
Study Protocol
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7238300/
https://ncbi.nlm.nih.gov/pubmed/32489433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920923431
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍